523 research outputs found
Kidney pathology and nephroprotection among patients with COVID-19
Π number of medical articles, documents and described clinical cases were studied to analyze the dependence of kidney function on COVID-19 disease. A number of conclusions were drawn about the significance of kidney involvement in the clinical picture of COVID-19 and the role of AKF in the adverse outcome. Risk factors from the kidneys for coronavirus infection and renal complications of COVID-19 were also established. In addition, the effect of drugs prescribed to patients with coronavirus infection on kidney function was analyzed. As a result, conclusions were drawn about events that could prevent kidney damage and improve the prognosis of life and recovery in patients with COVID-19.ΠΠ»Ρ Π°Π½Π°Π»ΠΈΠ·Π° Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΏΠΎΡΠ΅ΠΊ ΠΎΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ COVID-19 Π±ΡΠ» ΠΈΠ·ΡΡΠ΅Π½ ΡΡΠ΄ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
ΡΡΠ°ΡΠ΅ΠΉ, Π΄ΠΎΠΊΡΠΌΠ΅Π½ΡΠΎΠ² ΠΈ ΠΎΠΏΠΈΡΠ°Π½Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ»ΡΡΠ°Π΅Π². ΠΡΠ» ΡΠ΄Π΅Π»Π°Π½ ΡΡΠ΄ Π²ΡΠ²ΠΎΠ΄ΠΎΠ² ΠΎ Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½Π½ΠΎΡΡΠΈ ΠΏΠΎΡΠ΅ΠΊ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΡΡ ΠΊΠ°ΡΡΠΈΠ½Ρ COVID-19 ΠΈ ΡΠΎΠ»ΠΈ ΠΠΠ Π² Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠΌ ΠΈΡΡ
ΠΎΠ΄Π΅. Π’Π°ΠΊΠΆΠ΅ Π±ΡΠ»ΠΈ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Ρ ΡΠ°ΠΊΡΠΎΡΡ ΡΠΈΡΠΊΠ° ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ ΠΏΠΎΡΠ΅ΠΊ Π΄Π»Ρ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΊΠΎΡΠΎΠ½ΠΎΠ²ΠΈΡΡΡΠΎΠΌ ΠΈ ΠΏΠΎΡΠ΅ΡΠ½ΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ COVID-19. ΠΠΎΠΌΠΈΠΌΠΎ ΡΡΠΎΠ³ΠΎ, Π±ΡΠ»ΠΎ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½ΠΎ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ², Π½Π°Π·Π½Π°ΡΠ°Π΅ΠΌΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ Ρ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠΊΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ, Π½Π° ΡΡΠ½ΠΊΡΠΈΡ ΠΏΠΎΡΠ΅ΠΊ. ΠΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ ΡΡΠΎΠ³ΠΎ Π±ΡΠ»ΠΈ ΡΠ΄Π΅Π»Π°Π½Ρ Π²ΡΠ²ΠΎΠ΄Ρ ΠΎ ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΡΡ
, ΡΠΏΠΎΡΠΎΠ±Π½ΡΡ
ΠΏΡΠ΅Π΄ΠΎΡΠ²ΡΠ°ΡΠΈΡΡ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ ΠΏΠΎΡΠ΅ΠΊ ΠΈ ΡΠ»ΡΡΡΠΈΡΡ ΠΏΡΠΎΠ³Π½ΠΎΠ· ΠΆΠΈΠ·Π½ΠΈ ΠΈ Π²ΡΠ·Π΄ΠΎΡΠΎΠ²Π»Π΅Π½ΠΈΡ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ COVID-1
Clinical significance of the risk assessment of the cardioemobolic stroke in the patients of the senior age group outside depending on the attract fibrillation
An assessment of the risk of cardioembolic stroke in a sample of patients over 65 years old among patients with a cardiological hospital of the city clinical hospital number 14 in Yekaterinburg was carried out. The group included 60 patients (41 women, 19 men) aged from 65 to 94 years. The average age is 74 years. Patients were assessed on a CHA2DS2 βVASc scale regardless of the current presence of atrial fibrillation. The analysis of the obtained data was performed using the statistical package SPSS 20.0. According to the results of the survey, it was found out that 96% of patients had more than 2 points on the CHA2DS2 βVASc scale; in 40% of patients they had MI in anamnesis. It was revealed that only 5% had a history of atrial fibrillation. The result obtained has a high clinical significance, since it indicates the need to assess the risks of cardioembolic stroke in the older age group regardless of the presence of atrial fibrillation at the present time for timely medical prophylaxis.ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΠΎΡΠ΅Π½ΠΊΠ° ΡΠΈΡΠΊΠ° ΠΊΠ°ΡΠ΄ΠΈΠΎΡΠΌΠ±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΠ½ΡΡΠ»ΡΡΠ° Π² Π²ΡΠ±ΠΎΡΠΊΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΡΠ°ΡΡΠ΅ 65 Π»Π΅Ρ ΡΡΠ΅Π΄ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΊΠ°ΡΠ΄ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ° ΠΠΠβ14 Π³.ΠΠΊΠ°ΡΠ΅ΡΠΈΠ½Π±ΡΡΠ³Π°. Π Π³ΡΡΠΏΠΏΡ Π²ΠΎΡΠ»ΠΈ 60 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² (41 ΠΆΠ΅Π½ΡΠΈΠ½, 19 ΠΌΡΠΆΡΠΈΠ½) Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 65 Π΄ΠΎ 94 Π»Π΅Ρ (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ 74Β±8,29 Π³ΠΎΠ΄Π°). ΠΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΠΎΡΠ΅Π½ΠΊΠ° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎ ΡΠΊΠ°Π»Π΅ CHA2DS2 βVASc Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ Π½Π°Π»ΠΈΡΠΈΡ Π² ΡΠ΅ΠΊΡΡΠΈΠΉ ΠΌΠΎΠΌΠ΅Π½Ρ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΠΈ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ. ΠΠ½Π°Π»ΠΈΠ· ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
Π΄Π°Π½Π½ΡΡ
ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠ°ΠΊΠ΅ΡΠ° SPSS 20.0.ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π²ΡΡΡΠ½Π΅Π½ΠΎ, ΡΡΠΎ 96% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈΠΌΠ΅Π»ΠΈ Π±ΠΎΠ»Π΅Π΅ 2 Π±Π°Π»Π»ΠΎΠ² ΠΏΠΎ ΡΠΊΠ°Π»Π΅ CHA2DS2 βVASc, ΠΠ Π² Π°Π½Π°ΠΌΠ½Π΅Π·Π΅ Π²ΡΡΠ²Π»Π΅Π½ Ρ53,3% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ². ΠΡΡΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ Ρ Π»ΠΈΡΡ 5% Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π»Π°ΡΡ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠΉ ΡΠ΅Π·ΡΠ»ΡΡΠ°Ρ ΠΈΠΌΠ΅Π΅Ρ Π²ΡΡΠΎΠΊΠΎΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅, ΠΏΠΎΡΠΊΠΎΠ»ΡΠΊΡ ΡΠΊΠ°Π·ΡΠ²Π°Π΅Ρ Π½Π° Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΈΡΠΊΠΎΠ² ΠΊΠ°ΡΠ΄ΠΈΠΎΡΠΌΠ±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΠ½ΡΡΠ»ΡΡΠ° Π² ΡΡΠ°ΡΡΠ΅ΠΉ Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ Π½Π°Π»ΠΈΡΠΈΡ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΠΉ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ Π² ΡΠ΅ΠΊΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π΄Π»Ρ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½ΡΠΎΠ·Π½ΠΎΠΉ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ
Variants of systemic lupus erythematus debut. Clinical case
It is not easy to identify specific subtypes of SLE. Each patient has only his inherent symptoms, the course of the disease, the features of the development of exacerbations, comorbidity, the response to therapy, despite the mandatory criteria, SLE is an independent clinical and immunological option, that must be taken into account while dynamically observing and choosing treatment tactics. The clinical case of the patient with atypical manifestation of SLE debut is givenΠΡΠ΄Π΅Π»ΠΈΡΡ ΠΊΠΎΠ½ΠΊΡΠ΅ΡΠ½ΡΠ΅ ΡΡΠ±ΡΠΈΠΏΡ Π‘ΠΠ Π½Π΅ΠΏΡΠΎΡΡΠΎ. Π£ ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ Π±ΠΎΠ»ΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠ΅ΡΡΡΡ ΡΠΎΠ»ΡΠΊΠΎ Π΅ΠΌΡ ΠΏΡΠΈΡΡΡΠΈΠ΅ ΡΠΈΠΌΠΏΡΠΎΠΌΡ, ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΠΉ, ΡΠΎΠΏΡΡΡΡΠ²ΡΡΡΠ°Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ, ΠΎΡΠ²Π΅Ρ Π½Π° ΡΠ΅ΡΠ°ΠΏΠΈΡ, Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° ΠΎΠ±ΡΠ·Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΊΡΠΈΡΠ΅ΡΠΈΠ΅Π² Π‘ΠΠ β ΡΠ°ΠΌΠΎΡΡΠΎΡΡΠ΅Π»ΡΠ½ΡΠΉ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π²Π°ΡΠΈΠ°Π½Ρ, ΡΡΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΡΡΠΈΡΡΠ²Π°ΡΡ ΠΏΡΠΈ Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠΈ ΠΈ Π²ΡΠ±ΠΎΡΠ΅ ΡΠ°ΠΊΡΠΈΠΊΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ. ΠΠΏΠΈΡΠ°Π½ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ Ρ Π°ΡΠΈΠΏΠΈΡΠ½ΡΠΌ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ΠΌ Π΄Π΅Π±ΡΡΠ° Π‘Π
Problems of comorbidity in patient with diabetes mellitus and cardiovascular diseases
The aim of the study - to study the features of the mutual influence of type 2 diabetes mellitus and its severity on the development of cardiovascular pathology.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΈΜ Π²Π·Π°ΠΈΠΌΠ½ΠΎΠ³ΠΎ Π²Π»ΠΈΡΠ½ΠΈΡ ΡΠ°Ρ
Π°ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π±Π΅ΡΠ° 2 ΡΠΈΠΏΠ° ΠΈ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΈΜ (Π‘Π‘Π
Clinical and laboratory parallels in the diagnostics of chronic heart failure
The article provides an overview of the literature data, mainly over the past 15 years (2005-2020) ΠΎn chronic heart failure, features of pathogenesis, clinical picture and diagnosis of diseasesΠ ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ ΠΎΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΡ
Π΄Π°Π½Π½ΡΡ
ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π·Π° ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ 15 Π»Π΅Ρ (2005-2020) ΠΎ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΡ
ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠ°ΡΡΠΈΠ½Ρ ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈ
Vasculitis on the background of COVID-19 infection. Review of the literature. Clinical case
The article presents a literature review of the impact of a new coronavirus infection on the appearance of thrombotic microangiopathy, as well as cases of multisystem inflammatory syndrome. A clinical case of a patient with hemorrhagic vasculitis of post-viral etiology COVID 19, cutaneous form, is presented.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΠΉ ΠΎΠ±Π·ΠΎΡ Π²Π»ΠΈΡΠ½ΠΈΡ Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π½Π° ΠΏΠΎΡΠ²Π»Π΅Π½ΠΈΠ΅ ΡΡΠΎΠΌΠ±ΠΎΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΌΠΈΠΊΡΠΎΠ°Π½Π³ΠΈΠΎΠΏΠ°ΡΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠ»ΡΡΠ°ΠΈ ΠΌΡΠ»ΡΡΠΈΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°. ΠΡΠΈΠ²Π΅Π΄Π΅Π½ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Ρ Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π²Π°ΡΠΊΡΠ»ΠΈΡΠΎΠΌ ΠΏΠΎΡΡΠ²ΠΈΡΡΡΠ½ΠΎΠΉ ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ COVID 19, ΠΊΠΎΠΆΠ½ΠΎΠΉ ΡΠΎΡΠΌ
- β¦